Agusti Alentorn

11PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 27, 2026
Spatial analysis of paraneoplastic cerebellar degeneration in ovarian cancer with anti-Yo syndrome and SCA1.

|Mar 27, 2025
Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.

Hugo Hernández-Tost, Nicolas Weiss, Sylvain Choquet

|Oct 02, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret

|Aug 08, 2024
Epilepsy in Patients With Primary CNS Lymphoma: Prevalence, Risk Factors, and Prognostic Significance.

Oumaima Aboubakr, Caroline Houillier, Agusti Alentorn

|Jun 01, 2023
Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.

Patrick R Benusiglio, Fikret Elder, Mehdi Touat

|Jan 27, 2023
Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma.

Rana Salam, Alexa Saliou, Franck Bielle

Pageof 2

Frequent Collaborators

3 joint publications

Caroline Houillier

2 joint publications

Lucia Nichelli

2 joint publications

Sylvain Choquet

2 joint publications

Caroline Dehais